new research about diabetes type 2

June 24, 2021 — Across the world, type 2 diabetes is on the rise. A research group has discovered a new gene that may hold the key to preventing and treating lifestyle related diseases such as ...

The new research, published in the journal Nature Communications, offers a potential strategy for developing new therapies that could restore dysfunctional pancreatic beta-cells or, perhaps, even prevent Type 2 diabetes from developing. The new study shows that the beta-cells of Type 2 diabetes patients are deficient in a cell trafficking ...

The FDA approved a new treatment to improve blood sugar control in adults with type 2 diabetes, ... and Obesity in the FDA's Center for Drug Evaluation and Research. Type 2 diabetes, the most ...

Type 2 diabetes mellitus, the most frequent subtype of diabetes, is a disease characterized by high levels of blood glucose (hyperglycaemia). It arises from a resistance to and relative deficiency ...

Methods. In this trial involving participants with type 2 diabetes of less than 10 years' duration who were receiving metformin and had glycated hemoglobin levels of 6.8 to 8.5%, we compared the ...

Both are now adults, and both have Type 1 diabetes. My son was 6 months old when he was diagnosed. And that's when I changed my research plan. And my daughter, who's four years older than my son, became diabetic about 10 years later, when she was 14. When my son was diagnosed, I knew nothing about diabetes and had been working on how frogs ...

Large-scale study reveals new genetic details of diabetes. In experiments of unprecedented scale, investigators at Weill Cornell Medicine and the National Institutes of Health have revealed new aspects of the complex genetics behind Type 2 diabetes. Through these discoveries, and by providing a template for future studies, this research ...

In a potential game changer for patients with type 2 diabetes, a team of researchers at the Diabetes, Obesity, and Metabolism Institute (DOMI) at the Icahn School of Medicine at Mount Sinai has identified a therapeutic target for the preservation and regeneration of beta cells (β cells)—cells in the pancreas that produce and distribute insulin.

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the treatment of type 2 diabetes. The efficacy ...

I. Introduction. Diabetes mellitus, a metabolic disease defined by elevated fasting blood glucose levels due to insufficient insulin production, has reached epidemic proportions worldwide (World Health Organization, 2020).Type 1 and type 2 diabetes (T1D and T2D, respectively) make up the majority of diabetes cases with T1D characterized by autoimmune destruction of the insulin-producing ...

Surgery led to diabetes remission in roughly 28% of patients, compared with a remission rate of just 4% among the non-surgery group, according to the study results. More research has found that ...

The chronic complications of type 2 diabetes are a major cause of mortality and disability worldwide [ 1, 2 ]. Clinical research is the main way to gain knowledge about long-term diabetic complications and reduce the burden of diabetes. This allows for designing effective programs for screening and follow-up and fine-targeted therapeutic ...

Amelioration of Both Central and Peripheral Neuropathy in Mouse Models of Type 1 and Type 2 Diabetes by the Neurogenic Molecule NSI-189. Diabetes, 68(11), 2143-2154. Read more. ADA-funded researcher studying link between ageing and type 2 diabetes. One of the most important risk factors for developing type 2 diabetes is age.

There are many known risk factors for type 2 diabetes, including family members having it, being of African or Asian ancestry, high blood pressure, obesitym and polycystic ovary syndrome (PCOS ...

Prolonged benefits of bariatric surgery for patients with Type 2 Diabetes. People with type 2 diabetes who underwent bariatric surgery compared to medical or lifestyle interventions had better ...

A new study found that tiny biodegradable particles improved insulin sensitivity in the liver cells of humans and in diabetic mice, which could offer a promising new treatment for type 2 diabetes.

The ADA is committed to continuing progress in the fight against type 2 diabetes by funding research, including support for potential new treatments, a better understating of genetic factors, addressing disparities, and more. For specific examples of projects currently funded by the ADA, see below. Greg J. Morton, PhD.

Type 2 diabetes affects more than 38.4 million Americans, with an estimated 1.4 million new cases diagnosed every year, according to the Centers for Disease Control and Prevention.

In the U.K., the National Health Service (NHS) will roll out a program that will test the weight loss therapy in thousands of people living with type 2 diabetes. Breakthrough research shows that ...

By Andrew Stewart, MD, as told to Hallie Levine. Type 2 diabetes is one of the world's greatest health problems. It affects about 400 million people globally. If it's uncontrolled, it can lead ...

Type 2 diabetes accounts for 90% of all diabetes cases, with social risk factors such as high BMI, poor diet, environmental hazards, and low physical activity contributing to the burden.

Some people with type 2 diabetes—the most common type—keep blood glucose in check by making lifestyle changes, including diet and exercise. Medications can also help to control blood glucose. Clinical trials over the past few decades have found that bariatric surgery, or weight-control surgery, can also help control type 2 diabetes.

A new study has shown that risk scores based on our genes and gut bacteria can improve the prediction of diseases such as type 2 diabetes and prostate cancer over traditional risk factors alone.

Researchers forecasted the number of kids and teens who will be diagnosed with diabetes from 2017 to 2060 based on two scenarios: Constant incidence: If the rate of new cases stays the same, type 1 diabetes cases would remain about the same. Type 2 diabetes cases would increase about 70%. Total diabetes cases would increase about 12%.

University of Alabama at Birmingham W. Timothy Garvey, M.D., and Andrea Cherrington, M.D. researchers recently presented NIH-funded findings regarding differences in medication acceptance, quality of life, insulin secretion, mortality and other outcomes among four commonly used Type 2 diabetes medications.. The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE ...

New research being presented at this year's European Congress on Obesity (ECO) in Venice, Italy (12-15 May), identifies the optimum body weight range for adults with type 2 diabetes to minimize ...

Read on to learn more about this new research, plus how to make better beverage choices, whether you have prediabetes, have received a type 2 diabetes diagnosis or simply want to live a long ...

Sat, 30 March 2024, 9:00 am GMT-4 · 2-min read. Drinking less alcohol and reducing the risk of type 2 diabetes can help people cut their chances of dementia (Image: Stock) Lowering alcohol intake and reducing the risk of type 2 diabetes can dramatically slash the chances of dementia, according to the latest research from the University of Oxford.

For those suffering from type 2 diabetes, keeping an ideal body weight is always recommended. However, according to new research, those aged over 65 can still remain "moderately overweight" to ...